Genomic News and Research

RSS

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

A joint research carried out by MIPT scientists and Harvard researchers have presented retinal cells that can integrate into the retina.

19 Apr 2021

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Two researchers from the Université Libre de Bruxelles in Belgium, Fabrizio Pucci and Marianne Rooman, recently built a simplified computational model, called SpikePro, to predict the SARS-CoV-2 fitness from the amino acid sequence and structure of the spike protein. This study focuses on the spike protein’s stability and the binding affinity to the host receptor.

19 Apr 2021

New study sheds light on complex brain process that helps learn and form new memories

Making memories involves more than seeing friends or taking photos. The brain constantly adapts to new information and stores memories by building connections among neurons, called synapses. How neurons do this--reaching out arm-like dendrites to communicate with other neurons--requires a ballet of genes, signaling molecules, cellular scaffolding and protein-building machinery.

19 Apr 2021

USP7 inhibitors could increase the anticancer effects of CDK1 compounds in cancer patients

Understanding the components that control cell division is fundamental to understanding how life works and how alterations in this delicate process can cause diseases such as cancer.

19 Apr 2021

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.

17 Apr 2021

The shock and reality of catching Covid after being vaccinated

Robin Hauser, a pediatrician in Tampa, Fla., got covid in February. What separates her from the vast majority of the tens of millions of other Americans who have come down with the virus is this: She got sick seven weeks after her second dose of the Pfizer-BioNTech vaccine.

17 Apr 2021

Candidate coronavirus vaccines show promising results in early animal testing

A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.

17 Apr 2021

Complex patterns of genetic ancestry can provide insights into genetic, environmental factors of many diseases

The complex patterns of genetic ancestry uncovered from genomic data in health care systems can provide valuable insights into both genetic and environmental factors underlying many common and rare diseases--insights that are far more targeted and specific than those derived from traditional ethnic or racial labels like Hispanic or Black, according to a team of Mount Sinai researchers.

16 Apr 2021

Novel gene mutations may help identify patients with a specific form of muscular dystrophy

New research from the University of Minnesota Medical School found mutations in a novel gene that may help identify patients with a specific form of muscular dystrophy.

16 Apr 2021

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern - including B.1.1.7, a variant first identified in Kent - were a result of long-term infection in people with a weakened immune system.

16 Apr 2021

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

Chile and Uruguay emerged as model cases last year for their handling of the COVID-19 crisis and are among the top five countriesin the world with the most vaccine doses administered per 100 people daily.

15 Apr 2021

INRS professor receives CIHR funding for research on nasopharyngeal bacteria

Professor Frédéric Veyrier of the Institut national de la recherche scientifique has received $711,450 from the Canadian Institutes of Health Research for a project on bacteria of the nasopharynx, including Neisseria.

15 Apr 2021

New mathematical model predicts the spread of COVID-19

Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and the University of Illinois Urbana-Champaign (UIUC) have developed a new mathematical model for predicting how COVID-19 spreads.

15 Apr 2021

SARS-CoV-2 variants are widely spread across the Houston metropolitan area

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

14 Apr 2021

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

A new research paper posted to the medRxiv* preprint server describes the changes in genomic sequence observed during the course of infection in a patient on the drug tacrolimus, along with steroids, both potent immunosuppressants, and who also received convalescent plasma treatment. These mutations were observed to occur within three weeks from infection.

14 Apr 2021

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

The study, published in The Lancet, demonstrates that there is no evidence of a link between severe illness and death and lineage when comparing the B.1.1.7 lineage and other variants.

14 Apr 2021

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared with those infected with a different COVID-19 strain.

13 Apr 2021

Genomic News and Research

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

New study sheds light on complex brain process that helps learn and form new memories

USP7 inhibitors could increase the anticancer effects of CDK1 compounds in cancer patients

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

The shock and reality of catching Covid after being vaccinated

Candidate coronavirus vaccines show promising results in early animal testing

Complex patterns of genetic ancestry can provide insights into genetic, environmental factors of many diseases

Novel gene mutations may help identify patients with a specific form of muscular dystrophy

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

INRS professor receives CIHR funding for research on nasopharyngeal bacteria

New mathematical model predicts the spread of COVID-19

SARS-CoV-2 variants are widely spread across the Houston metropolitan area

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

New approach to scale up genome editing in tiny worms

Low health literacy may discourage men from selecting active surveillance for prostate cancer

UHN performed first double-lung transplant after COVID-19 in Canada

The art of CRISPR: The power and promise of gene editing eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News